AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli
Open Access
- 5 September 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 19 (1), 1-7
- https://doi.org/10.1186/s12866-019-1589-1
Abstract
Efflux pump mediated antibiotic resistance is an unnoticed and undetected mechanism in clinical microbiology laboratory. RND efflux systems are known for aminoglycoside and tetracycline resistance whereas their role in carbapenem non-susceptibility is not established. The study was undertaken to investigate the role of efflux pump in providing resistance against carbapenems and their response against concentration gradient carbapenem stress on the transcriptional level of the AcrAB gene in the clinical isolates of Escherichia coli from a tertiary referral hospital of Northeast India. Out of 298 non-susceptible Escherichia coli isolates 98 isolates were found to have efflux pump mediated carbapenem non-susceptibility. Among them thirty-five were non carbapenemase producers and their expressional levels were verified using qRT-PCR under concentration gradient carbapenem stress. In this study, a strong correlation between ertapenem resistance and AcrA overexpression was observed which has not been reported previously. Further, it was observed that imipenem stress increased AcrB expression in Escherichia coli which holds the novelty of this study. Additionally, the transcription of AcrR was insistently increased which is much higher than the transcriptional level of AcrA under concentration gradient carbapenem stress condition. The study established that AcrAB pump is a relevant antibiotic resistance determinant in bacterial pathogen, has an important role in developing resistance against carbapenem group of antibiotics.Keywords
This publication has 30 references indexed in Scilit:
- Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter ProteinsScience, 2006
- Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolatesBiochemical Journal, 2003
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York CityClinical Infectious Diseases, 2003
- Imipenem and expression of multidrug efflux pump in Enterobacter aerogenesBiochemical and Biophysical Research Communications, 2003
- Substrate Specificity of the RND-Type Multidrug Efflux Pumps AcrB and AcrD of Escherichia coli Is Determined Predominately by Two Large Periplasmic LoopsJournal of Bacteriology, 2002
- Molecular characterization of metallo-b-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettesJournal of Antimicrobial Chemotherapy, 2002
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species from a bone marrow transplant recipientMolecular Pathology, 2000
- Multidrug resistance mechanisms: drug efflux across two membranesMolecular Microbiology, 2000
- AcrD of Escherichia coli Is an Aminoglycoside Efflux PumpJournal of Bacteriology, 2000